News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
819,566 Results
Type
Article (75913)
Company Profile (643)
Press Release (743010)
Multimedia
Podcasts (124)
Webinars (14)
Section
Business (228171)
Career Advice (3775)
Deals (39213)
Drug Delivery (129)
Drug Development (89292)
Employer Resources (198)
FDA (17857)
Job Trends (17120)
News (388388)
Policy (38812)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (6)
2025 BioForest Digital (6)
2025 Lone Star Bio Digital (9)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2999)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (91)
Alliances (56201)
ALS (98)
Alzheimer's disease (1495)
Antibody-drug conjugate (ADC) (154)
Approvals (17821)
Artificial intelligence (295)
Autoimmune disease (28)
Automation (16)
Bankruptcy (402)
Best Places to Work (12632)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (440)
Bladder cancer (73)
Brain cancer (31)
Breast cancer (294)
Cancer (2332)
Cardiovascular disease (200)
Career advice (3215)
Career pathing (34)
CAR-T (167)
Cell therapy (467)
Cervical cancer (21)
Clinical research (72035)
Collaboration (891)
Compensation (538)
Complete response letters (30)
COVID-19 (2861)
CRISPR (45)
C-suite (255)
Cystic fibrosis (107)
Data (2153)
Decentralized trials (2)
Denatured (43)
Depression (53)
Diabetes (290)
Diagnostics (6904)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (135)
Drug pricing (125)
Drug shortages (33)
Duchenne muscular dystrophy (100)
Earnings (94033)
Editorial (43)
Employer branding (25)
Employer resources (167)
Events (128743)
Executive appointments (754)
FDA (19138)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (800)
Gene editing (115)
Generative AI (31)
Gene therapy (340)
GLP-1 (845)
Government (5124)
Grass and pollen (6)
Guidances (52)
Healthcare (20871)
Huntington's disease (25)
IgA nephropathy (28)
Immunology and inflammation (143)
Indications (29)
Infectious disease (3021)
Inflammatory bowel disease (150)
Inflation Reduction Act (11)
Influenza (56)
Intellectual property (97)
Interviews (741)
IPO (17709)
IRA (51)
Job creations (4979)
Job search strategy (2627)
Kidney cancer (11)
Labor market (42)
Layoffs (548)
Leadership (22)
Legal (9922)
Liver cancer (79)
Lung cancer (335)
Lymphoma (152)
Machine learning (6)
Management (65)
Manufacturing (337)
MASH (73)
Medical device (14600)
Medtech (14605)
Mergers & acquisitions (22029)
Metabolic disorders (772)
Multiple sclerosis (84)
NASH (23)
Neurodegenerative disease (109)
Neuropsychiatric disorders (34)
Neuroscience (2079)
NextGen: Class of 2025 (7636)
Non-profit (5078)
Northern California (2667)
Now hiring (40)
Obesity (419)
Opinion (274)
Ovarian cancer (76)
Pain (93)
Pancreatic cancer (84)
Parkinson's disease (158)
Partnered (22)
Patents (244)
Patient recruitment (109)
Peanut (51)
People (64148)
Pharmaceutical (132)
Pharmacy benefit managers (21)
Phase I (22241)
Phase II (31402)
Phase III (23700)
Pipeline (1190)
Policy (167)
Postmarket research (3280)
Preclinical (9829)
Press Release (72)
Prostate cancer (105)
Psychedelics (38)
Radiopharmaceuticals (268)
Rare diseases (423)
Real estate (7168)
Recruiting (75)
Regulatory (26038)
Reports (57)
Research institute (2654)
Resumes & cover letters (589)
Rett syndrome (4)
RNA editing (4)
RSV (50)
Schizophrenia (78)
Series A (141)
Series B (89)
Service/supplier (27)
Sickle cell disease (58)
Southern California (2309)
Special edition (18)
Spinal muscular atrophy (165)
Sponsored (34)
Startups (4191)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (38)
The Weekly (79)
United States (24002)
Vaccines (799)
Venture capitalists (44)
Weight loss (301)
Women's health (38)
Worklife (19)
Date
Today (110)
Last 7 days (686)
Last 30 days (2648)
Last 365 days (35362)
2025 (10664)
2024 (37924)
2023 (42567)
2022 (53927)
2021 (58722)
2020 (57665)
2019 (51316)
2018 (39098)
2017 (36866)
2016 (37817)
2015 (43846)
2014 (38604)
2013 (34746)
2012 (36606)
2011 (36665)
2010 (36227)
Location
Africa (1201)
Alabama (59)
Alaska (7)
Arizona (249)
Arkansas (14)
Asia (48527)
Australia (8348)
California (6227)
Canada (2014)
China (542)
Colorado (278)
Connecticut (291)
Delaware (149)
Europe (110417)
Florida (908)
Georgia (216)
Hawaii (1)
Idaho (63)
Illinois (599)
India (30)
Indiana (329)
Iowa (12)
Japan (164)
Kansas (108)
Kentucky (27)
Louisiana (14)
Maine (70)
Maryland (944)
Massachusetts (4785)
Michigan (241)
Minnesota (412)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (62)
New Hampshire (69)
New Jersey (1769)
New Mexico (31)
New York (1764)
North Carolina (1105)
North Dakota (8)
Northern California (2667)
Ohio (214)
Oklahoma (15)
Oregon (46)
Pennsylvania (1379)
Puerto Rico (12)
Rhode Island (35)
South America (1575)
South Carolina (23)
South Dakota (1)
Southern California (2309)
Tennessee (104)
Texas (928)
Utah (188)
Virginia (164)
Washington D.C. (69)
Washington State (592)
West Virginia (3)
Wisconsin (64)
819,566 Results for "pharmacia and upjohn diagnostics gmbh and co kg".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioNxt Signs Letter of Intent with Gen-Plus GmbH & Co KG for Potential Business Collaborations
August 15, 2024
·
3 min read
Press Releases
Enclara Pharmacia Launches Next-Day Shipping Infusion Services to Support Hospice Providers
April 9, 2025
·
2 min read
Deals
Luciole Medical AG Announces the Acquisition of Spiegelberg GmbH & Co. KG to Create a Leading Global Brain Monitoring Developer and Provider
Luciole Medical AG, a Swiss medical technology company specialized in brain monitoring, announced the acquisition of Spiegelberg GmbH & Co. KG, an established medical device company and provider of highly specialized devices and consumables for neurosurgery, from SHS Capital.
June 27, 2023
·
4 min read
Press Releases
Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH
March 19, 2025
·
1 min read
Press Releases
Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results
March 28, 2025
·
10 min read
Press Releases
Enclara Pharmacia Announces Patient Record Integration with FireNote Hospice EMR
January 21, 2025
·
2 min read
Genetown
Akebia Therapeutics Enters into License Agreement with Medice Arzneimittel Pütter GmbH&Co.KG for the Commercialization of Vafseo® for the Treatment of Anemia associated with CKD in Europe and Australia
Akebia Therapeutics®, Inc. (Nasdaq: AKBA) today announced an agreement with MEDICE Arzneimittel Pütter GmbH&Co.KG (Medice – The Health Family), for Medice to market Vafseo® (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor developed by Akebia to treat anemia due to chronic kidney disease (CKD), in Europe.
May 25, 2023
·
7 min read
Press Releases
Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH
April 22, 2025
·
6 min read
Deals
Calibre Scientific Acquires DCS, a German Provider of Antibodies, Reagents and Equipment Used in Immunohistochemistry
Calibre Scientific is pleased to announce the acquisition of DCS Innovative Diagnostik-Systeme GmbH & Co. KG (“DCS” or the “Company”), a German supplier of reagents and equipment used in immunohistochemistry for the diagnostic, research, industrial, university and hospital industries, with a focus on clinical pathology and oncology end markets.
June 19, 2024
·
2 min read
Business
Secarna Pharmaceuticals and Orbit Discovery Enter Collaboration to Discover and Develop Peptide-conjugated Targeted Antisense Oligonucleotide Therapeutics
Secarna Pharmaceuticals GmbH & Co. KG and Orbit Discovery Ltd. today announced that they have entered into a collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide (ASO) therapeutics.
May 28, 2024
·
2 min read
1 of 81,957
Next
